The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.

Login
EN
+7 (495) 482-4118
+7 (495) 482-4329
+8 800 250-18-12
  • (toll-free number for subscriptions)
    Mon-Fri from 10 a.m. to 6 p.m.

  • © 1998-2026
+7 (495) 482-43-29
EN
All journals
Journal
Year
Year
Search result: 0

Parfenov V.A.

Pervyĭ Moskovskiĭ gosudarstvennyĭ meditsinskiĭ universitet im. I.M. Sechenova, Moskva

Pozhidaev K.A.

Sechenov First Moscow State Medical University, Moscow, Russia

The use of vazobral in chronic cerebral ischemia and headache

Authors:

Parfenov V.A., Pozhidaev K.A.

More about the authors

Journal: S.S. Korsakov Journal of Neurology and Psychiatry. 2018;118(9): 126‑129

DOI: 10.17116/jnevro2018118091126

Read: 2792 times

Download PDF (RU)
Contact the author
Table of contents

THE USE OF VAZOBRAL IN CHRONIC CEREBRAL ISCHEMIA AND HEADACHE
THE USE OF VAZOBRAL IN CHRONIC CEREBRAL ISCHEMIA AND HEADACHE

To cite this article:

Parfenov VA, Pozhidaev KA. The use of vazobral in chronic cerebral ischemia and headache. S.S. Korsakov Journal of Neurology and Psychiatry. 2018;118(9):126‑129. (In Russ.)
https://doi.org/10.17116/jnevro2018118091126

Подписка 2026 Журнал неврологии и психиатрии им. С.С. Корсакова (S.S. Korsakov Journal of Neurology and Psychiatry)
МСФ на ЯМ
Использование инфографики авторами научных работ
Close metadata
Recommended articles:
Biochemical features of migraine pathogenesis. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(4):21-26
Morning headaches in patients with obstructive sleep apnea syndrome: Pathogenesis, differential diagnosis, and treatment. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(5-2):92-97
Treatment features of patients with vascular cognitive impairments. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(5):69-76
Expe­rience of using reamberin for correction of cognitive status in patients with chro­nic cere­bral ischemia. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(5):84-88
Quantitative and qualitative asse­ssment of the complete blood count in patients with obstructive sleep apnea and chro­nic ischemia. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(5):95-102
Targets of rational neuroprotection in the therapy of chro­nic cere­bral ischemia and the possibilities of achieving them. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(8):96-101
Study of the levo­carnitine effi­cacy for the treatment of mode­rate cognitive impairment in patients with hype­rtension. Russian Journal of Preventive Medi­cine. 2025;(4):45-50
Recu­rrent pain syndromes in adolescents of different ages. Russian Journal of Pain. 2025;(2):24-31
Prophylactic treatment of migraine in real clinical practice. Russian Journal of Pain. 2025;(2):63-69
Biofeedback in complex therapy of pain syndromes. Russian Journal of Pain. 2025;(2):70-75
Abstract:

The authors describe manifestations of chronic cerebral ischemia (CCI) and present the cases of a combination of primary headache and CCI. Management of patients with CCI and headache and the use of vazobral and its efficacy in treatment of such patients are discussed.

Keywords:

chronic cerebral ischemia
discirculatory encephalopathy
vascular cognitive impairment
stroke prevention
primary headaches
migraine
vasobral

Authors:

Parfenov V.A.

Pervyĭ Moskovskiĭ gosudarstvennyĭ meditsinskiĭ universitet im. I.M. Sechenova, Moskva

Pozhidaev K.A.

Sechenov First Moscow State Medical University, Moscow, Russia

Close metadata

References:

  1. Gusev EI, Bogolepova AN. Cognitive disorders in cerebrovascular diseases. M.: MEDpress-inform; 2013. (In Russ.)
  2. Gusev EI, Chukanova EI. Modern pathogenetic aspects of the formation of chronic cerebral ischemia. Zhurnal Nevrologii i Psihiatrii im. S.S. Korsakova. 2015;115(3):4-8. (In Russ.)
  3. Parfenov VA, Zaharov VV, Preobrazhenskaya IS. Cognitive disorders. M.: Remedium; 2014. (In Russ.)
  4. Parfenov VA. Dyscirculatory encephalopathy and vascular cognitive disorders. M.: IMA-PRESS; 2017. (In Russ.)
  5. Valenzuela MJ. Cerebrovascular disease, cognitive impairment and dementia. Cerebrovascular disease and dementia. 2nd ed. Edited by O’Brien J, Ames D, Gustafson L. London; N.Y.: Martin Dunitz; 2004.
  6. Gorelick PB, Scuteri A, Black SE, Decarli C, Greenberg SM, Iadecola C, Launer LJ, Laurent S, Lopez OL, Nyenhuis D, Petersen RC, Schneider JA, Tzourio C, Arnett DK, Bennett DA, Chui HC, Higashida RT, Lindquist R, Nilsson PM, Roman GC, Sellke FW, Seshadri S. Vascular Contributions to Cognitive Impairment and Dementia: A Statement for Healthcare Professionals From the American Heart Association/American Stroke Association. Stroke. 2011;42:2672-2713.
  7. Sachdev P, Kalaria R, O’Brien J, Skoog I, Alladi S, Black SE, Blacker D, Blazer DG, Chen C, Chui H, Ganguli M, Jellinger K, Jeste DV, Pasquier F, Paulsen J, Prins N, Rockwood K, Roman G, Scheltens P. Diagnostic criteria for vascular cognitive disorders: a VASCOG statement. Alzheimer Dis Assoc Disord. 2014;28(3):206-218.
  8. Samorodskaya IV, Andreev EM, Zarat’yanc OV, Kosivtsova OV, Kakorina EP. Mortality rates of the population older than 50 years from cerebrovascular diseases over a 15-year period in Russia and the United States. Nevrologiya, Nejropsihiatriya i Psihosomatika. 2017;9(1):15-24. (In Russ.)
  9. Yaxno NN, Levin OS, Damulin IV. Comparison of clinical and MRI data with discirculatory encephalopathy. Message 2: cognitive impairment. Nevrologicheskij Zhurnal. 2001;6(3):10-19. (In Russ.)
  10. Preobrazhenskaya IS, Yahno NN. Vascular cognitive impairment: clinical manifestations, diagnosis, treatment. Nevrologicheskij Zhurnal. 2007;12(5):45-50. (In Russ.)
  11. Yahno NN, Zaharov VV, Lokshina AB, Koberskaya NN, Mxitaryan EA. Dementia. M.: Medpress-inform; 2011. (In Russ.)
  12. Shmidt EV. Classification of vascular lesions of the brain and spinal cord. Zhurnal Nevropatologii i Psihiatrii im. S.S. Korsakova. 1985;85(9):1281-1288. (In Russ.)
  13. Filatova EG, Istomina OI. Treatment of chronic daily headache. Klinicheskaya Nevrologiya. 2011;1:30-35. (In Russ.)
  14. The International Classification of Headache Disorders, 3rd edition (beta version). Cephalalgia. 2013;33(9):629-808.
  15. Golovacheva VA, Parfenov VA, Tabeeva GR, Osipova VV, Smulevich AB, Andrushchenko AV, Golovacheva AA Optimization of management of patients with chronic daily headache. Zhurnal Nevrologii i Psihiatrii im. S.S. Korsakova. 2017;117(2):4-9. (In Russ.)
  16. Osipova VV, Tabeeva GR. Primary headaches. Practical Guidance. M.: MIA; 2014. (In Russ.)
  17. Peng J, Lu F, Wang Z, Zhong M, Sun L, Hu N, Liu Z, Zhang W. Excessive lowering of blood pressure is not beneficial for progression of brain white matter hyperintensive and cognitive impairment in elderly hypertensive patients: 4-year follow-up study. J Am Med Dir Assoc. 2014;15:904-910.
  18. Bath PM, Scutt P, Blackburn DJ, Ankolekar S, Krishnan K, Ballard C, Burns A, Mant J, Passmore P, Pocock S, Reckless J, Sprigg N, Stewart R, Wardlaw JM, Ford GA; PODCAST Trial Investigators. Intensive versus guideline blood pressure and lipid lowering in patients with previous stroke: Main results from the pilot «Prevention of Decline in Cognition after Stroke Trial» (PODCAST) Randomised Controlled Trial. PLoS One. 2017;12(1):e0164608.
  19. Spinelli C, de Caro MF, Schirosi G, Mezzapesa D, De Benedittis L, Chiapparino C, Serio G, Federico F, Nazzaro P. Impaired cognitive executive dysfunction in adult treated hypertensives with a confirmed diagnosis of poorly controlled blood pressure. Int J Med Sci. 2014;11:771-778.
  20. Solomon A, Mangialasche F, Richard E, Andrieu S, Bennett DA, Breteler M, Fratiglioni L, Hooshmand B, Khachaturian AS, Schneider LS, Skoog I, Kivipelto M. Advances in the prevention of Alzheimer’s disease and dementia. J Intern Med. 2014;275(3):229-250.
  21. European Stroke Organisation (ESO) Executive Committee; ESO Writing Committee. Guidelines for management of ischaemic stroke and transient ischaemic attack. Cerebrovasc Dis. 2008;25:457-507.
  22. Shinohara M, Sato N, Shimamura M, Kurinami H, Hamasaki T, Chatterjee A, Rakugi H, Morishita R. Possible modification of Alzheimer’s disease by statins in midlife: interactions with genetic and non-genetic risk factors. Front Aging Neurosci. 2014;6:71.
  23. Herrmann N, Lanctot KL, Hogan DB. Pharmacological recommendations for the symptomatic treatment of dementia: the Canadian Consensus Conference on the Diagnosis and Treatment of Dementia 2012. Alzheimers Res Ther. 2013;5(suppl 1):5.
  24. Olin J, Schneider L, Novit A, Luczak S. Hydergine for dementia. Cochrane Database Syst Rev. 2000;3:CD000359.
  25. Baskys A, Hou AC. Vascular dementia: Pharmacological treatment approaches and perspectives. Clin Intervent Aging. 2007;2:327-335.
  26. Kamchatnov PR. The results of using the drug vasobral in patients with chronic disorders of cerebral circulation. Zhurnal Nevrologii i Psihiatrii im. S.S. Korsakova. 2011;111(10):70-72. (In Russ.)
  27. Tabeeva GR, Azimova Yu.Eh. Migraine is an emphasis on preventive treatment. Spravochnik Poliklinicheskogo Vracha. 2010;9(8):55-58 (In Russ.)
Contact the author
Email
Message
The publishing house "Media Sphere" does not provide treatment services, does not give recommendations on contacting medical institutions and specific specialists, on the prescription of medicines and dietary supplements.

Email Confirmation

An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.

Email Confirmation

Submit Application

You can become an author of one of our magazines, send a request and we will consider it in during the day.

Name
Phone
E-mail
Message
Login
Registration
E-mail
Password
Forgot Password?

Log in to the site using your account in one of the services

Password recovery
E-mail
Login
Register

We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.